null - FindTrial

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-005436-26-FR

Enrollment

Registered

2012-02-07

Start date

2012-03-12

Completion date

Unknown

Last updated

2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Product Name: Panitumumab Pharmaceutical Form: Solution for infusion INN or Proposed INN: PANITUMUMAB CAS Number: 339177-26-3 Concentration unit: mg/kg milligram(s)/kilogram Concentration type: range

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 25 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 20

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactFFCD

Fédération Francophone de Cancérologie Digestive

marie.moreau@u-bourgogne.fr33380668013

Outcome results